business of life sciences

  • Sam Patrick posted an article
    SC Commerce's Bobby Hitt, Abbott's Tom Strange, Nephron saluted by SCBIO see more

    Nearly 350 industry leaders on hand to salute inaugural honorees for commitment to advancing South Carolina’s booming life sciences industry

     

     NOVEMBER 2, 2018 – To resounding applause from a record gathering from 4 countries, 22 states and virtually every county in South Carolina, life sciences leaders saluted three leaders – two individuals and one organization – for profound positive impact and exceptional contributions to the advancement of South Carolina’s $11.4 billion life sciences industry.

     South Carolina Secretary of Commerce Robert M. “Bobby” Hitt III was presented with the inaugural South Carolina Life Sciences Hall of Fame Award for his personal championing of the life sciences industry, which today has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products.  SC Commerce is a Founding Partner and strategic supporter of SCBIO, and has been highly instrumental in helping the rapid growth of life sciences in the Palmetto State.

     Mr. Hitt has served as South Carolina Secretary of Commerce since January 2011. Promoting a team-first approach to economic development, Hitt has positioned the S.C. Department of Commerce and its many partners and allies for industry recruitment success. Since 2011, Team South Carolina has recruited more than $35 billion in capital investment and approximately 125,000 new jobs to the state. This year alone, multiple world-class companies have made significant investments in South Carolina, including BMW, Samsung and Volvo Cars.  Before his time as Secretary of Commerce, Hitt served as manager of Corporate Affairs at the BMW Manufacturing Company in Spartanburg County after 17 years as managing editor of The State and Columbia Record newspapers.

     Presented with the inaugural South Carolina Life Sciences Pinnacle Award for Individual Contribution to the industry was Tom Strange, Senior Director of Research & Development for Abbott Labs in Liberty, South Carolina.  With an extensive background in materials science, Mr. Strange holds 48 patents and has authored numerous papers covering all aspects of capacitor development. He began his illustrious career with Philips Components in 1979 leading research activity involving development of capacitors that made thoracic implantable cardioverter defibrillators possible. Today, with over 20 years at St Jude Medical/Abbott, his team continues to define state of the art in implantable medical devices for pacing and arrhythmia correction, neuromodulation and battery performance. 

    Honored for his exceptional industry-related contributions and profound impact on the state, its citizens and the life sciences industry, Mr. Strange led efforts to establish SC Launch!, the public/private initiative with the SC legislature to fund start-up activities in SC under SCRA, and helped to launch SCBIO as an affiliate of the national BIO organization. He holds numerous honors and awards, and earned undergraduate and graduate degrees in Physics from the University of South Carolina.

    Presented with the inaugural South Carolina Life Sciences Pinnacle Award for Organizational Contribution to the industry was Nephron Pharmaceuticals of West Columbia, represented by owners Lou and Bill Kennedy.  A Vision Partner of SCBIO, CEO Lou Kennedy joined Nephron Pharmaceuticals in 2001, and was named President/CEO in 2007. She led the creation of a state of the art manufacturing facility in West Columbia in 2014, and oversaw development of a national sales force which helped Nephron grow by 300% and increased shipped product to over one billion doses annually. 

    Honored for Nephron’s economic, innovation, social and quality of life impact in the state, the Kennedy’s helped establish the Kennedy Pharmacy Innovation Center in conjunction with the USC School of Pharmacy. Ms. Kennedy serves on or chairs numerous boards including those of SCBIO, the SC Chamber of Commerce, the National Bank of South Carolina, and the South Carolina Manufacturers Alliance.

    The three honorees joined BIO global CEO Jim Greenwood and more than 50 additional national speakers at SCBIO 2018 – the annual conference which brought top leaders and executives from life sciences organizations across the state and nation to Charleston, South Carolina October 23-25.

    Included among attendees were scores of top industry chief executives, leaders in government and higher education, biotechnology and pharma executives, clinicians and researchers, and industry supporters from across America including DePuy Synthes Global Orthopedic Leader I.V. Hall, J.P. Morgan Executive Director of Healthcare Investment Banking Bell Zhong, MUSC President David Cole, USC President Harris Pastides, Siemens Healthineers North Americas President Dave Pacitti, and numerous others.

    SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry has an $11.4 billion economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products. 

    “The life sciences industry is a major driver of South Carolina’s economy, and these noted honorees and this conference is testament to the industry’s growing impact, reach and rapidly rising economic significance in our state and region,” noted SCBIO President and CEO Sam Konduros. “We’re pleased to honor them for their many contributions, and salute them for the advances they have facilitated for this industry.”

    As the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations – SCBIO members include hundreds of academic institutions, biotech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products that transform how we heal, fuel and feed the world.

    For additional information on SCBIO, visit www.SCBIO.org.

  • Sam Patrick posted an article
    SCBIO's expanded Board of Directors includes life sciences leaders from across South Carolina see more

    Organization’s Boards spans state, industry segments to provide unique blend of expertise for advancing South Carolina’s life sciences industry

     

    GREENVILLE, SC – February 8, 2019 – Less than two years after initiating a comprehensive relaunch of the state’s official life sciences organization, SCBIO has expanded its Board of Directors for its 501c6 operational entity and added a second 10-member Board for its 501c3 research and educational arm for 2019.  It does so having authored the state’s first-ever life sciences strategic growth plan, conducted an economic impact study validating the contributions of the $11.4 billion industry, tripled revenues and quadrupled membership – all since Spring 2017.

    And according to SCBIO President and CEO Sam Konduros, the best and most exciting days for the industry and organization are still ahead of it.

    “In a state perhaps best known for building BMWs and Boeing Dreamliners, there is a very strong life sciences story brewing as well, creating opportunities to diversify and accelerate growth of our state’s knowledge economy,” said Konduros recently.  He further cited rapid growth of such national and global brands including Nephron Pharmaceuticals, Arthrex, ZEUS, Abbott, Thorne and AVX as just a few examples of the state’s rapidly rising life sciences industry, which currently spans more than 400 companies in 44 counties and employs over 15,000 well-paid associates.

    Leading the policy- and strategy-making efforts of the 501c6 entity of the non-profit organization, the Board of Directors meets regularly to receive updates on SCBIO business objectives, domestic and global initiatives, and to help hone strategies and offer insight.  Nephron Pharmaceuticals Corporation CEO Lou Kennedy will serve as SCBIO’s 2019 Board Chair; Stephanie Yarbrough, Womble Bond Dickinson, LLP as Vice Chair; Michael Rusnak, Medical University of South Carolina Research Foundation as Treasurer; and Josh Ridley of ZEUS as Secretary. 

    Jeff Stover of Haynsworth Sinkler Boyd, PA will serve as Legal Officer; Heather Simmons Jones of the Greenwood Partnership Alliance as Annual Conference Officer; Bryan Davis of Prisma/Greenville Health System’s Office of Innovations as Healthcare/Innovation Officer; Adam Hoots of DPR Construction as Talent/Workforce Officer; and Sam Konduros, President and CEO of SCBIO. 

    Recently added members of the SCBIO Board of Directors are:

    Mike Briggs – President & CEO, Central SC Alliance

    Caroline Brown – Director of External Affairs, Medical University of South Carolina

    Thornton Kirby – President & CEO, South Carolina Hospital Association

    Adam Klonecke – Senior Site Director, Abbott

    Angie Leidinger – VP of External Affairs, Clemson University

    Tom McKenna – Chief Operating Officer, Thorne

    Robert Ryan – CEO & Founder, Innova Therapeutics

    Dave Shalaby – President, Poly-Med, Inc.

    Will Williams – President & CEO, Economic Development Partnership (Aiken)

    Cynthia Young – Dean, Clemson University College of Science

     

    Returning members of the SCBIO Board for 2019 are:

    Mandy Brawley – South Carolina Department of Commerce

    Matthew Couvillion – Wyche Law Firm

    John J. Darby – Johnson & Johnson Services

    Tressa Gardner – SE Institute of Manufacturing & Technology

    Mike Graney – Charleston Regional Development Alliance

    Chad Hardaway – University of South Carolina Office of Economic Engagement

    Will Harms – Blue Cross Blue Shield of SC

    Erica Jackson – K&L Gates

    Marc Metcalf – Upstate SC Alliance

    Kathy Phlegar – Phlegar & Associates

    Christine Dixon Thiesing – SCRA

    Courtney Warren – Marsh & McLennan Agency

     

    Comprising the smaller Board of SCBIO’s 501c3 research and educational arm are Kathryn Becker of Translational Science Solutions; Michael Bolick of Treis Blockchain; Matthew Couvillion of Wyche Law Firm; Shontavia Johnson of Clemson University; Steve Johnson of SCRA; Chris Przirembel, retired Clemson University executive; Shawn Regan of Rhythmlink; Craig Walker of Hitachi Healthcare Americas; Erica Jackson of K&L Gates; and SCBIO CEO Sam Konduros.

    SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products.  The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in advanced medicines, medical devices, diagnostics, IT, and healthcare outcome industries.

    SCBIO is the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations.  SCBIO members include academic institutions, biotech companies, med-tech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotech and med-tech products that will make a difference across the Palmetto State, and around the world.

  • Sam Patrick posted an article
    Top life sciences leaders from across the state have been named to the SCBIO Executive Committee see more

    Leadership team provides strategic blend of economic development, industry, higher education expertise

     

    GREENVILLE, SC – January 17, 2019 – SCBIO has announced its 2019 Executive Committee following formal confirmation at the life science organization’s December 2018 meeting in Columbia.  Nephron Pharmaceuticals Corporation CEO Lou Kennedy will serve a second term as SCBIO’s 2019 Board Chair.

    Ms. Kennedy joined Nephron Pharmaceuticals in 2001, and assumed the position of President and CEO in 2007. She has held a variety of marketing and operational roles during her career and has helped Nephron Pharmaceuticals grow by more than 300% and increased shipped product to one billion doses each of the last seven years.  Nephron constructed a state of the art manufacturing facility in West Columbia, South Carolina and, with her husband Bill, helped establish the Kennedy Pharmacy Innovation Center in conjunction with the USC School of Pharmacy.  The organization was honored as an inaugural winner of the South Carolina Life Sciences Pinnacle Award for Organizational Contribution to the industry in October, 2018.

    Joining Ms. Kennedy on the SCBIO Executive Committee will be Stephanie Yarbrough, Partner with Womble Bond Dickinson, LLP as Vice Chair; Michael Rusnak, Executive Director of the MUSC Foundation for Research Development as Treasurer; and Josh Ridley, Global Business Development Director of ZEUS as Secretary.  

    Additional members of the Executive Committee are Jeff Stover, Special Counsel with Haynsworth Sinkler Boyd, PA as Legal Officer; Heather Simmons Jones, CEO of the Greenwood Partnership Alliance as Annual Conference Officer; Bryan Davis, Operations Manager with Greenville Health System’s Office of Innovations as Healthcare/Innovation Officer; Adam Hoots, Life Sciences Market Leader for DPR Construction as Talent/Workforce Officer; and Sam Konduros, President and CEO of SCBIO. 

    Recognized for completing their terms as contributing members of the SCBIO Executive Committee were former Vice Chair Craig Walker, executive with Hitachi Healthcare Americas, and former Secretary Kathryn Becker, Principal with Translational Science Solutions LLC.

    SCBIO President and CEO Konduros praised the Executive Committee noting, “With the critically important efforts we are undertaking to advance pharmaceuticals, life sciences R&D, biotech, med-tech, and the health IT industries in South Carolina, we require strong, expert leadership from across the state, fully integrating our business, education and economic development sectors. These diverse leaders who represent the width and breadth of our state and industry will effectively champion our vision of building the business of life sciences in South Carolina for years to come.”

    SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry already has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products.  The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in the advanced medicines, medical devices, equipment, diagnostics, IT, and healthcare outcome industries.

    The Executive Committee and Board of Directors is the policy- and strategy-making body of the organization, and meets regularly to receive updates on SCBIO business and objectives, as well as domestic and global initiatives. The Executive Committee serves roles specific to SCBIO operations, focus areas and strategies.

    SCBIO is the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations.  SCBIO members include academic institutions, biotech companies, med-tech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotech and med-tech products that will make a difference across the Palmetto State, and around the world.

    For additional information on SCBIO, visit www.SCBIO.org

  • Sam Patrick posted an article
    TSO3 to Commercialize the STERIZON VP4 Sterilizer and Support Getinge Transition see more

    Myrtle Beach, United States and Quebec City, Canada August 1st, 2018 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices, today announced that TSO3 and a fund (the “Fund”) of which Courage Capital Management LLC, (“Courage”) is the investment advisor, have entered into a binding US$20 million debt financing to fund commercialization initiatives for its STERIZONE® VP4 Sterilizer, the only terminal sterilization method that is FDA cleared to sterilize multi-channeled flexible endoscopes (with a maximum of four channels) of up to 3.5 meters in length, such as certain colonoscopes, gastroscopes and duodenoscopes. Courage is a Nashville, TN headquartered alternative asset management firm with a 20-year track record of investments in health care services, medical devices, and pharmaceuticals.

    Concurrent with the Courage financing, TSO3 and Getinge Infection Control AB (“Getinge”) mutually decided not to renew the distribution agreements between the parties, and have agreed to: 1) provide TSO3 unrestricted independent commercialization of its STERIZONE® VP4 Sterilizers; 2) the Company’s purchase of approximately 230 STERIZONE® VP4 Sterilizers, 220 of which are from Getinge’s inventory, for $33,000 per sterilizer; 3) transfer Getinge’s existing sales pipeline to TSO3 in exchange for shared economics at the completion of sale; and 4) transition to TSO3 the service, maintenance and consumables sales of all existing STERIZONE® VP4 Sterilizer customers in the United States and Canada. Getinge and TSO3 envision maintaining an ongoing collaborative relationship where TSO3 supplies and supports the STERIZONE® VP4 Sterilizer to satisfy Getinge customers looking for a total sterilization solution.

    About the STERIZONE® VP4 Sterilizer

    The STERIZONE® VP4 Sterilizer is a low-temperature sterilization system that utilizes the dual sterilants of vaporized hydrogen peroxide (H2O2) and ozone (O3) to achieve terminal sterilization of heat and moisturesensitive medical devices. Its single pre-programmed cycle can sterilize a large number and wide range of compatible devices, creating a cost-effective sterilization process with error-free cycle selection. The device’s unique Dynamic Sterilant Delivery System™ automatically adjusts the quantity of injected sterilant based on the 3 load composition, weight and temperature. This capability removes the guesswork and potential for human error, as there is no need to sort instruments and choose the appropriate cycles as with other machines.

    The STERIZONE® VP4 Sterilizer is the only terminal sterilization method that is FDA cleared to sterilize multichanneled flexible endoscopes (with a maximum of four channels) of up to 3.5 meters in length, such as video colonoscopes, duodenoscopes and gastroscopes – an industry first for any medical device sterilization process.

    The STERIZONE® VP4 Sterilizer is also the only cleared low temperature sterilizer that can process a mixed load consisting of general instruments, single channel flexible endoscopes, and single or double channel rigid endoscopes in the same cycle with load weights of up to 75 lb. The ability to run mixed loads significantly reduces labor costs by minimizing the amount of instrument sorting required, while maximizing the device turns (more productivity from increased throughput capacity).

    More information about the STERIZONE® VP4 Sterilizer is available through TSO3‘s website, under the Products section.

    About TSO3

    Founded in 1998, TSO3‘s activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.

    To read more about any of the following, please click here:

  • Sam Patrick posted an article
    Greenville-based Zylö Therapeutics is utilizing regional chemical/mechanical engineering in new ways see more

    Once home to a thriving textile industry replete with chemical and mechanical engineers working to improve the soil and machinery converting raw cotton into commercial goods, upstate South Carolina may be on the precipice of its next industrial revolution: medtech.

     

    Born from technology developed at the Albert Einstein College of Medicine, Greenville-based Zylö Therapeutics is utilizing the regional chemical/mechanical engineering expertise and support network to improve drug and nitric oxide delivery through a proprietary sustained delivery system called Nanopods. 

    Read the entire story here, courtesy of Medical Design & Outsourcing...

  • Sam Patrick posted an article
    A Charleston neighborhood is being transforned into a hotbed for life sciences firms see more

    A plan from the early 2000s to transform part of Charleston’s Westside neighborhood into a hotbed for life sciences firms, medical device companies and innovative medical research is now in motion.

    A large-scale development known as WestEdge is in the works on land bounded by Lockwood Boulevard, Fishburne Street, Hagood Avenue and Spring Street. A few hotels and office buildings, Brittlebank Park, Joseph P. Riley Jr. Park and expansive gravel parking lots dot that part of the Westside today.

     

    Read full details from the Charleston Regional Business Journal report here...

  • Sam Patrick posted an article
    SEMDA Medtech 2018 is coming to Greenville, SC May 2-4. see more

    Conference Registration Surging for Initial Appearance in Greenville, SC as Southeastern medtech industry continues rapid scale up


    Greenville, SC – April 17, 2018 -- The Southeastern Medical Device Association (SEMDA) -- a non-profit trade association focused on making the Southeast a world-class region for medical technology, device, and diagnostic companies – has announced an initial group of featured speakers for the 2018 SEMDA Medtech Conference May 2-4, 2018.

    For the first time ever, the annual Southeastern showcase of who’s who and what is happening in medtech will convene in South Carolina, with the Hyatt Regency Greenville serving as headquarters hotel.

    Among the featured speakers announced today that have committed to present at the conference are Joe Lee, Executive Director of Life Sciences for JP Morgan; Andy Fish, Chief Strategy Officer of AdvaMed; and Denise Hines, North American Chair of the Health Information & Management Systems Society and current CEO of eHealth Services Group.  Also speaking will be Lee Burnes, Vice President of Global Research & Development at Halyard Health; and Jim Stefansic, Chief Executive Officer of Raiven Healthcare

    Additional featured speakers are expected to be named shortly, and companies engaged in presenting to industry executives in the PitchRounds program, co-sponsored by SCRA, SCBIO and Eversheds Sutherland, will be announced within the week.  PitchRounds is a highly targeted event for both start-ups and “Seed” companies as well as later-stage (Series A or later) organizations to present ideas, innovations and products to panels of institutional investors, regulatory leaders, venture capital directors, IP experts and others in structured sessions.  Selected participants receive individual feedback on their presentations and compete for $10,000 in top prize money.

    “The South Carolina medtech industry has been a strong supporter of SEMDA for many years and is growing at one of the fastest rates in the country, so we are excited to tap into the growth and excitement in the industry by bringing this preeminent event to the Palmetto State for the first time,” said Jason Rupp, Executive Director of SEMDA.  “Most importantly, we are thrilled to unveil members of a stellar group of industry experts who will be presenting to members drawn from across the Southeastern United States and to industry attendees from across North America.”

    The SEMDA conference typically attracts more than 400 executives in medtech and life sciences from throughout the United States and has become a must-attend for the medtech community. Registration is currently surging, noted Mr. Rupp, and a full house of medtech industry leaders is again expected.  Persons interested in attending can review the agenda, speakers and registration details online at http://www.semda.net.

    Joe Lee, who will keynote Day 2 of the conference, is Executive Director of Life Sciences for JP Morgan and leads the Middle Market Banking coverage of life science companies across the Southeast. Well-known and respected in life science industry circles, Mr. Lee will discuss key opportunity areas for growth in the Southeast and provide rapid-growth companies with counsel on how to prepare their organizations for success in the competitive space.

    Andrew Fish is Chief Strategy Officer of AdvaMed, the leading trade association advancing medical technology in the U.S. and around the world. As chief strategy officer, Mr. Fish leads the association’s strategic planning, oversees AdvaMed's global, regulatory, and payment departments, and coordinates the development and operations of AdvaMed’s membership divisions and sectors.

    Dr. Denise Hines is current Chair of the North America Board of the Health Information & Management Systems Society (HIMSS), and is actively involved in HIMSS’ Women in Health IT initiatives that promote diversity and recognition.  She is CEO of eHealth Services Group and serves as Executive Director of Georgia’s statewide health information exchange (HIE).

    Lee Burnes is Vice President of Global R&D for Halyard Health where the organization is focused on development of products, technologies and solutions that prevent infection, eliminate pain and speed recovery.  Prior to joining Halyard, Lee successfully led numerous R&D organizations at Covidien.

    Jim Stefansic serves as President and CEO of Raiven Healthcare, a provider of healthcare artificial intelligence and data analytics solutions. An accomplished entrepreneur, Jim has years of experience launching and growing numerous healthcare technology businesses.  He previously was co-founder and COO of Pathfinder Therapeutics, Inc., where he helped bring industry-leading image-guided surgical products to market.

    “These presenters and others we will announce shortly demonstrates that SEMDA has evolved into a truly regional organization that embraces and represents the collective of medtech startups, universities, corporate organizations, investment resources and capabilities across the southeastern United States,” Mr. Rupp said.  “The conference provides a great opportunity to interact with other companies, investors, customers, partners, and specialized service providers.”

    # # #

     

    About SEMDA

    The Southeastern Medical Device Association (SEMDA) is a regional non-profit trade association that supports and promotes medical device and medical device data system (MDDS) companies in the Southeast. Created in 2004, the association provides unique educational resources to accelerate device development and achieve commercial success with access to funding, education, and networking opportunities for medical device companies, inventors, physicians, investors, tech transfer offices, universities, sponsors, and service providers interested in growing the medical device industry in the Southeast.

  • Sam Patrick posted an article
    South Carolina Innovators, Inventors convene at SEMDA conference to present to Venture Capitalists see more

    State’s Innovators, Inventors, convene at conference to present to Venture Capitalists

     

    GREENVILLE, SC – April 6, 2018 – The Southeastern Medical Device Association (SEMDA) -- a non-profit trade association driven to make the southeast a world-class region for medical technology, device, and diagnostic companies – brings its 2018 conference to South Carolina for the first time May 2-4, 2018, attracting hundreds of executives to Greenville to meet, negotiate, learn, network and grow the medical device industry in the Southeast.

    Focused on accelerating device development and helping organizations and individuals gain access to funding, education, and networking opportunities, the annual conference is a must-attend for medical device companies, inventors, physicians, investors, tech transfer offices, universities, and service providers interested in growing the medical device industry in North America, and even globally.

    As part of SEMDA 2018’s many activities, SCBIO and SCRA are collaborating to present PitchRounds 2018 – a highly targeted venue for both start-ups and “Seed” companies as well as later-stage (or Series A or later) organizations to present their ideas, innovations and products to panels of institutional investors, regulatory leaders, venture capital directors, IP experts and others in structured sessions. 

    Selected participants will receive individual feedback on their presentations and compete for $10,000 in top prize money for selected winners.  Participating presenters also receive two full conference registrations and access to meet with investors and partners at sessions and networking receptions.  Global law firm Eversheds Sutherland, one of the 50 largest law firms globally, is also a co-sponsor of PitchRounds.

    Applying to present is both free and simple, with full details available online at www.SEMDA.net/conference/pitchrounds or at www.SCBIO.org.  The deadline to complete the simple application to be considered is close of business April 13, 2018.

    SCBIO Vice President Erin Ford noted, “SCBIO and our co-sponsors are delighted to make PitchRounds a possibility for South Carolina’s emerging medtech companies to showcase their innovations and solutions, and to directly access investors and industry leaders to gain direct feedback on their innovations.”

    “While entries will be considered from across the entire Southeast and presentation spots are limited, we are confident that South Carolina will be well represented based on the robust pipeline of innovations the South Carolina life sciences community has been working on.  We encourage all early- and later-stage companies to enter the PitchRounds program and showcase the Palmetto State’s talents.”

    SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms and 15,000 professionals directly involved in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products.  The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in the advanced medicines, medical devices, equipment, diagnostics, IT, and healthcare outcome industries.

    SCBIO is the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations.  SCBIO members include academic institutions, biotech companies, med-tech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotech and med-tech products that will make a difference across the Palmetto State, and around the world.

  • Sam Patrick posted an article
    A cardiac technologist in South Carolina has invented a solution to catheter-associated UTIs see more

    James Conner, a cardiac technologist at Bon Secours St. Francis Health System in Greenville, SC has invented a device that alerts health care providers at the first sign of hospital-acquired infection caused by urinary catheters.  Read full story...

  • Sam Patrick posted an article
    Zeus Industrial continued its growth announcements, revealing plans to expand again in Aiken, SC. see more

    Polymer Extrusion Manufacturer Creating 51 New Jobs

    Zeus Industrial Products (Zeus), a leading polymer extrusion manufacturer and material science innovator, is expanding its existing operations in Aiken County. The company’s $15.7 million investment in Aiken County complements a $15.9 million expansion in Orangeburg County and $76 million expansion in Calhoun County, both of which were announced over the last several weeks. With this project, Zeus is expected to create an additional 51 new jobs in Aiken, S.C.

    Founded in 1966, Zeus develops and manufacturers polymer tubing for a variety of industries, including the medical, fluid handling and electrical markets. Zeus works with customers in collaborative relationships to design, engineer and produce fluoropolymer and specialized plastic tubing that delivers the temperature resistance, chemical resistance and high tensile strength demanded by today’s applications.

    Located at 9150 Levels Church Road West in Aiken, S.C., Zeus intends to convert its warehousing operations and floor space to manufacturing space in order to increase production of existing products by installing additional manufacturing lines. The plant will also be increasing its product portfolio as several new products and new manufacturing processes are introduced over the next few years.

    The initial hiring for these new positions has already begun and will continue into 2019. Interested applicants should visit the company’s zeusinc.com/careers for more information.

    The Coordinating Council for Economic Development has approved job development credits related to the project.

    QUOTES

    “We are truly excited about expanding our manufacturing presence in Aiken. We have been pleased with the community support that we have received since commencing our Aiken operations in 1999. We remain committed to being a good citizen of the county, meeting and exceeding the needs of our customers, and most importantly, providing quality careers for all of our employees in an atmosphere that will allow them to flourish.” – Zeus Industrial Products, Inc. President and CEO John Winarchick

    “This expansion by Zeus is an affirmation that Aiken County continues to provide an environment for manufacturing growth. We are excited that this company will add more jobs for our citizens.” –Aiken County Council Chairman Gary Bunker

    “We are very grateful for this expansion announcement by Zeus. This is a great win for Aiken County, and we look forward to more growth by Zeus in our region.” –Economic Development Partnership Chairman Gary Stooksbury
     

    FIVE FAST FACTS

    • Zeus Industrial Products is expanding its Aiken County operations.
    • $15.7 million investment to create 51 new jobs.
    • This project complements a $76 million Calhoun County expansion and $15.9 million Orangeburg County expansion, both of which were announced recently.
    • Located at 9150 Levels Church Road West in Aiken, S.C., the company will beconverting its warehousing operations into manufacturing space in order to increase production of existing products.
    • Hiring for the initial positions is already underway and will continue into 2019, and interested applicants should visit zeusinc.com/careers for more information.

  • Sam Patrick posted an article
    Industry subject matter experts to cover what businesses need to know about state industry see more

    GREENVILLE, SC – February 14, 2018 – SCBIO will host a half-day program March 14, 2018 -- South Carolina Life Sciences Boot Camp: Essentials of a Growing Industry – to inform and update businesses and professionals from across the state on opportunities, trends and issues facing South Carolina’s fastest-growing industry segment.

    To be held at the University of South Carolina’s Arnold School of Public Health in Columbia, the program will run from 8:30 a.m. until 12:30 p.m. and will feature a light breakfast followed by presentations from over half a dozen noted life sciences industry leaders.  Confirmed presenters and their topics are:

    • Burnie Maybank, Author of the SC Life Sciences Act; Partner, Nexsen Pruet, “Life Sciences industry Economic Development Incentives”
    • Stephanie Yarbrough, Partner, Womble Bond Dickinson, “M&A 101 in the Life Sciences Space”
    • Kathryn Cole Becker, Principal, Translational Science Solutions, “FDA 101 for Medical Devices”
    • Jeff Stover, Partner, Haynsworth Sinkler Boyd, “IP Essentials for Life Sciences”
    • John Osborne, Partner, Good Growth Capital, “Introduction to Life Science Innovation & Entrepreneurship”
    • Public Policy Hot TopicsSpeaker to be announced

    Attendance is free to SCBIO members and employees of SCBIO member companies, and available for only $75 to Non-Members.  Advance registration is required, and space is limited.  To register, visit www.SCBIO.org/Events

    SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products.  The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in the advanced medicines, medical devices, equipment, diagnostics, IT, and healthcare outcome industries.

    SCBIO is the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations.  SCBIO’s diverse membership is leading research and development of innovative healthcare, agricultural, industrial and environmental biotech and med-tech products that will make a difference across the Palmetto State, and around the world.

    For additional information on SCBIO, visit www.SCBIO.org.

  • Sam Patrick posted an article
    Zylö Therapeutics is locating new operations in Greenville County, SC. see more

    GREENVILLE, S.C. – Zylö Therapeutics, a developer of state-of-the-art technology for the pharmaceutical industry, is locating new operations in Greenville County. The company is expected to create 30 new jobs.

     

    Zylö Therapeutics has developed an innovative sustained-release drug-delivery system that delivers traditionally hard-to-deliver therapeutic agents through topical administration. With more than 10 years of research and development, the second generation of this technology continues to improve, providing 24-hour sustained release of a variety of agents, including nitric oxide, curcumin, lidocaine and more.

     

    Zylö Therapeutics is headquartered at the NEXT on Main facility at 101 North Main Street in Greenville, S.C. NEXT is a program of the Greenville Chamber of Commerce that currently supports more than 100 knowledge-based companies in Upstate South Carolina.

    Zylö Therapeutics’ operations will soon include a lab facility, where formulation and product development work will be performed. Those interested in joining the Zylö Therapeutics team should visit www.zylotherapeutics.com for more information.

     

    QUOTES

     

    “With the bulk of our scientists and advisors located in the Northeast corridor, we considered a variety of alternative locations, but Greenville represents a wonderful balance of small-town feel, sophistication, high growth and vibrancy. In addition, the city offers a wealth of start-up resources that will assuredly work to our advantage over time.” – Zylö Therapeutics CEO Scott Pancoast

     

    “To see a company like Zylö Therapeutics choose to invest in our state and our people is an important sign to the business community around the world that South Carolina is the place to be. We’ve worked hard to create a pro-business environment and cultivate a highly-trained workforce, and those efforts continue to pay off.” –Gov. Henry McMaster

     

    “The success of South Carolina’s booming life sciences industry continues to impress, and I congratulate Zylö Therapeutics on today’s tremendous announcement. Over the last two decades, we’ve seen a major transformation in South Carolina’s economy, and innovative companies like Zylö Therapeutics are responsible for it.” –Secretary of Commerce Bobby Hitt

     

    “Greenville County encourages growth in the bioscience sector of our economy. We are proud to welcome Zylö Therapeutics to Greenville as part of our vibrant bioscience community that is pioneering state-of-the-art technologies at the forefront of modern medicine. We wish great success for Zylö Therapeutics.” –Greenville County Council Chairman H.G. “Butch” Kirven Jr.

     

    “Greenville has become increasingly attractive to industry leaders in next-generation medical care, as innovative companies like Zylö Therapeutics seek environments that can help connect resources, support emerging technologies and supply a dedicated workforce. The City of Greenville is thrilled to welcome Zylö to our vibrant downtown and we look forward to being a part of their company’s growth.” –City of Greenville Mayor Knox White

     

    “We are excited to welcome Zylö Therapeutics as the newest member of NEXT and the Greenville startup community. This high-impact, knowledge-based company further strengthens the more-than-150 companies within this vibrant, entrepreneurial ecosystem.” –NEXT CEO John Moore


    FIVE FAST FACTS

     

    • Zylö Therapeutics is locating new operations in Greenville County.
    • The start-up is projected to create 30 new jobs.
    • Zylö Therapeutics is a developer of patented, state-of-the-art technology for the pharmaceutical industry.
    • Headquartered in Suite 315 at 101 North Main Street in Greenville, S.C., the company’s operations will include a laboratory facility focused on formulation and product development.
    • Those interested in joining the Zylö Therapeutics team should visit www.zylotherapeutics.com for more information. 

  • Sam Patrick posted an article
    Hitachi Healthcare Americas Corp. has entered an agreement to acquire Greenville, SC's VidiStar, LLC see more

    Twinsburg, OH January 9, 2018 - Hitachi Healthcare Americas Corporation, a wholly owned subsidiary of Hitachi, Ltd. (TSE: 6501) and a leading provider of medical imaging modalities to hospital and ambulatory clients nationwide, today announced that it has entered into an agreement to acquire VidiStar, LLC, a Greenville, SC-based company focused on reinventing how doctors review and report on diagnostic exams to drive productivity, portability, and improved communication and clinical decision making. Hitachi expects that the acquisition of VidiStar will advance the company's informatics strategy and analytics capabilities to improve workflow and intelligence for physicians, particularly with those providers conducting diagnostic ultrasound examinations.

    "VidiStar has developed a cloud-based diagnostic viewer and customizable structured reporting solution for medical imaging and clinical decision support. With VidiStar, physicians can interpret exams over the web and deliver improved visualization and timely results with the extended care teams.” said William Burns, Senior VP, Hitachi Healthcare Americas.

    “We are very excited about VidiStar becoming part of the Hitachi team and believe this partnership will further our client’s ability to reduce inefficiencies in clinical and operational workflows. We will work together to create the next generation of healthcare informatics and analytics solutions so providers and healthcare professionals can take full advantage of the power of informatics." said Craig Walker, CEO of Vidistar.

    “This acquisition will add significant talent and expertise in expanding our Healthcare Informatics business at Hitachi. As the healthcare market transitions from volume to value-based care, structured reporting and advanced analytics will play a critical role in enabling and supporting this transition.” said Yasuhiko Taniguchi, CEO of Hitachi Healthcare Americas.

    Structured reporting can help standardize and improve the quality of clinical reports and streamline communication among care teams while reducing errors. Advanced analytics and data mining can help identify key value drivers, improve decision making, and ensure that providers and healthcare professionals are informed and efficient in their mission to deliver high quality care.

    Upon completion of the transaction, VidiStar and its employees will become part of the Hitachi Healthcare Americas business group within Hitachi. VidiStar will maintain its current headquarters office in Greenville, SC.

    About VidiStar, LLC 

    VidiStar, LLC is based in Greenville, SC (USA) and has developed a web-based diagnostic viewer and patented structured reporting solution (US Pat. No. 8,200,505) for medical imaging and clinical decision support. VidiStar's technology allows physicians and healthcare providers the ability to read and interpret diagnostic studies over the internet for timely interpretation, improved patient diagnosis, clinical decision support, and advanced patient data analytics and notification. VidiStar is a 2012 and 2013 Innovision Award Winner and a 2008 and 2010 SCLaunch Portfolio Company.

    About Hitachi Healthcare Americas Corporation

    Hitachi Healthcare Americas Corporation, located in Twinsburg, Ohio, a wholly owned subsidiary of Hitachi, Ltd. offers a broad range of diagnostic imaging equipment including MRI, CT and Ultrasound. Hitachi’s MRI, CT and Ultrasound technologies provide speed, comfort and quality for both physicians and patients alike and play an important role in the diagnosis and treatment of disease while driving social innovation into healthcare. Visit www.hitachihealthcare.com.

     About HitachiLtd

    Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges. The company’s consolidated revenues for fiscal 2016 (ended March 31, 2017) totaled 9,162.2 billion yen ($81.8 billion). The Hitachi Group is a global leader in the Social Innovation Business, and it has approximately 304,000 employees worldwide. Through collaborative creation, Hitachi is providing solutions to customers in a broad range of sectors, including Power / Energy, Industry / Distribution / Water, Urban Development, and Finance / Government & Public / Healthcare. For more information on Hitachi, please visit the company’s website at http://www.hitachi.com/.

  • Sam Patrick posted an article
    Eight story office and lab building named 22 WestEdge breaks ground in Charleston, SC see more

    The third multistory building set to rise in the developing WestEdge community on the Charleston peninsula broke ground Thursday — under a tent because of all the recent rain.

    The eight-story office and laboratory structure called 22 WestEdge will sit next to the under-construction, nine-story 10 WestEdge building at Spring Street and Lockwood Drive. That’s where Publix supermarket is set to open on the ground floor in October.

    The first floor of the all-glass exterior structure will house 15,750 square feet of retail space while the upper floors will provide 138,500 square feet of office space-targeted firms in the so-called knowledge economy, such as the life sciences industry. About half of the site has already been leased.

    Read on here for the full story from The Post and Courier.